首页> 外文期刊>Biotechnology and Applied Biochemistry >Fibrin as a scaffold for cardiac tissue engineering
【24h】

Fibrin as a scaffold for cardiac tissue engineering

机译:纤维蛋白作为心脏组织工程的支架

获取原文
获取原文并翻译 | 示例
       

摘要

Fibrin is a natural biopolymer with many interesting properties, such as biocompatibility, bioresorbability, ease of processing, ability to be tailored to modify the conditions of polymerization, and potential for incorporation of both cells and cell mediators. Moreover, the fibrin network has a nanometric fibrous structure, mimicking extracellular matrix, and it can also be used in autologous applications. Therefore, fibrin has found many applications in tissue engineering, combined with cells, growth factors, or drugs. Because a major limitation of cardiac cell therapy is low cell engraftment, the use of biodegradable scaffolds for specific homing and in situ cell retention is desirable. Thus, fibrin-based injectable cardiac tissue engineering may enhance cell therapy efficacy. Fibrin-based biomaterials can also be used for engineering heart valves or cardiac patches. The aim of this review is to show cardiac bioengineering uses of fibrin, both as a cell delivery vehicle and as an implantable biomaterial.
机译:纤维蛋白是一种天然的生物聚合物,具有许多有趣的特性,例如生物相容性,生物再吸收性,易于加工,可以修改聚合条件的能力以及细胞和细胞介体的掺入潜力。此外,血纤蛋白网络具有模仿细胞外基质的纳米纤维结构,也可用于自体应用。因此,纤维蛋白已与细胞,生长因子或药物结合在组织工程中发现了许多应用。由于心脏细胞治疗的主要局限性是低细胞植入,因此希望使用可生物降解的支架进行特异性归巢和原位细胞保留。因此,基于纤维蛋白的可注射心脏组织工程可以增强细胞疗法的功效。基于纤维蛋白的生物材料也可用于工程心脏瓣膜或心脏贴片。这篇综述的目的是显示纤维蛋白作为细胞递送载体和可植入生物材料的心脏生物工程用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号